Role of adjuvant treatment in stage IB non-small cell lung carcinoma

被引：0
作者：
Park, Cheol-Kyu [1 ,2 ]
Oh, In-Jae [1 ,2 ]
Kim, Young-Chul [1 ,2 ,3 ,4 ]
机构：
[1] Chonnam Natl Univ, Dept Internal Med, Med Sch, Jeonnam, South Korea
[2] Hwasun Hosp, Jeonnam, South Korea
[3] Chonnam Natl Univ, Dept Internal Med, Med Sch, 322 Seoyang Ro, Hwasun 58128, South Korea
[4] Hwasun Hosp, 322 Seoyang Ro, Hwasun 58128, South Korea
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2023年 / 12卷 / 03期
关键词：
Adjuvant treatment; non-small-cell lung carcinoma; stage IB; CISPLATIN; CHEMOTHERAPY; OSIMERTINIB; THERAPY; CANCER;
D O I：
10.21037/tlcr-2023-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：649 / 652
页数：4
相关论文
共 50 条
  • [21] Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
    Shukla, Nikhil
    Hanna, Nasser
    LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 51 - 60
  • [22] De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer
    Bryant, Alex K.
    Sankar, Kamya
    Zhao, Lili
    Strohbehn, Garth W.
    Elliott, David
    Moghanaki, Drew
    Kelley, Michael J.
    Ramnath, Nithya
    Green, Michael D.
    EUROPEAN JOURNAL OF CANCER, 2022, 171 : 55 - 63
  • [23] Diagnosis, treatment, and prognosis of stage IB non-small cell lung cancer with visceral pleural invasion
    Ruan, Zegang
    Zhuo, Xin
    Xu, Chenyang
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [24] Adjuvant treatment of non-small cell lung cancer: focus on targeted therapy
    Tazza, Marco
    Metro, Giulio
    JOURNAL OF THORACIC DISEASE, 2017, 9 (10) : 4064 - 4069
  • [25] Oral targeted therapy for the treatment of non-small cell lung carcinoma
    Phillips, William J.
    Leighl, Natasha B.
    Blais, Normand
    Wheatley-Price, Paul
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2024, 196 (16) : E558 - E561
  • [26] Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis
    Kann, Benjamin H.
    Miccio, Joseph A.
    Stahl, John M.
    Ross, Rudi
    Verma, Vivek
    Dosoretz, Arie P.
    Park, Henry S.
    Shafman, Timothy D.
    Gross, Cary P.
    Yu, James B.
    Decker, Roy H.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 188 - 196
  • [27] Benefits of adjuvant chemotherapy in elderly patients with stage IB-IIIB non-small cell lung cancer: a propensity-matched analysis
    Qin, Xuan
    Xiao, Xiangzhi
    Xia, Hongwei
    Yang, Ke
    Zhang, Shengchao
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (06) : 3003 - 3015
  • [28] Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer
    Serke, Monika
    CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 135 - 144
  • [29] Adjuvant Therapy for Stage I and II Non-Small Cell Lung Cancer
    Naylor, Evan C.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 585 - +
  • [30] Benefit of adjuvant chemotherapy for patients with stage IB non-small cell lung cancer: a systematic review and meta-analysis
    Wang, Xiaofan
    Chen, Donglai
    Wen, Junmiao
    Mao, Yiming
    Zhu, Xuejuan
    Fan, Min
    Chen, Yongbing
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (18)
12345